Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality

British Journal of Cancer

Volumn 107, Issue 12, 2012, Pages 2016-2023

  Masuda, S ^a,b   Kadowaki, T ^b   Kumaki, N ^b   Tang, X ^a,b   Tokuda, Y ^b   Yoshimura, S ^b   Takekoshi, S ^b   Osamura, R Y ^c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

breast cancer; cell lineage; clonality; D loop; mitochondria DNA

Indexed keywords

ANDROGEN RECEPTOR; FORMALDEHYDE; MITOCHONDRIAL DNA; PARAFFIN;

ADULT; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER TISSUE; CLINICAL ARTICLE; CLONAL VARIATION; D LOOP; DNA DETERMINATION; DNA ISOLATION; DNA SEQUENCE; DNA STRUCTURE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER MICRODISSECTION; LYMPH NODE; MALE; MAMMARY GLAND; METASTASIS; MUTATIONAL ANALYSIS; PRIMARY TUMOR; PRIORITY JOURNAL; RECURRENT CANCER; X CHROMOSOMAL INHERITANCE;

ADULT; AGED; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, X; CLONE CELLS; DNA, MITOCHONDRIAL; FEMALE; FORMALDEHYDE; HUMANS; LASER CAPTURE MICRODISSECTION; LYMPH NODES; MAMMARY GLANDS, HUMAN; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN;

EID: 84870828143     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.505     Document Type: Article

References (38)

1. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J,Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ,Staden R, Young IG (1981) Sequence and organization of the humanmitochondrial genome. Nature 290(5806): 457-465
2. Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP (2008)Clonality of lobular carcinoma in situ (LCIS) and metachronous invasivebreast cancer. Breast Cancer Res Treat 107(3): 331-335
3. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, KaracaG, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC,Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breastcancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA295(21): 2492-2502
4. Chatterjee A, Dasgupta S, Sidransky D (2011) Mitochondrial subversion incancer. Cancer Prev Res (Phila) 4(5): 638-654
5. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer.I. The value of histological grade in breast cancer: experience from alarge study with long-term follow-up. Histopathology 19(5): 403-410
6. Fan AX, Radpour R, Haghighi MM, Kohler C, Xia P, Hahn S, Holzgreve W,Zhong XY (2009) Mitochondrial DNA content in paired normal andcancerous breast tissue samples from patients with breast cancer. JCancer Res Clin Oncol 135(8): 983-989
7. Giles RE, Blanc H, Cann HM, Wallace DC (1980) Maternal inheritance ofhuman mitochondrial DNA. Proc Nat Acad Sci USA 77(11): 6715-6719
8. Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kestin LL (2005a)Molecular clonality relationships in initial carcinomas, ipsilateral breastfailures, and distant metastases in patients treated with breastconservingtherapy: evidence suggesting that some distant metastasesare derived from ipsilateral breast failures and that metastases canmetastasize. Am J Clin Pathol 124(1): 49-57
9. Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kraus D,Kestin LL (2005b) Molecular clonality determination of ipsilateralrecurrence of invasive breast carcinomas after breast-conservingtherapy: comparison with clinical and biologic factors. Am J Clin Pathol123(5): 679-689
10. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C (1996)Ipsilateral breast tumor recurrence as a predictor of distant disease:implications for systemic therapy at the time of local relapse. J Clin Oncol14(1): 52-57
11. Karrison TG, Ferguson DJ, Meier P (1999) Dormancy of mammarycarcinoma after mastectomy. J Natl Cancer Inst 91(1): 80-85
12. Kollias J, Man S, Marafie M, Carpenter K, Pinder S, Ellis IO, Blamey RW,Cross G, Brook JD (2000) Loss of heterozygosity in bilateral breastcancer. Breast Cancer Res Treat 64(3): 241-251
13. Lee HC, Chang CM, Chi CW (2010) Somatic mutations of mitochondrialDNA in aging and cancer progression. Ageing Res Rev 9(Suppl 1):S47-S58
14. Linder D, Gartler SM (1965) Glucose-6-phosphate dehydrogenase mosaicism:utilization as a cell marker in the study of leiomyomas. Science150(3692): 67-69
15. Lyon MF (1961) Gene action in the X-chromosome of the mouse (Musmusculus L.). Nature 190: 372-373
16. Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung SC, SukumarS, Sidransky D (2005) Tumor-specific changes in mtDNA content inhuman cancer. Int J Cancer 116(6): 920-924
17. Mashal RD, Lester SC, Sklar J (1993) Clonal analysis by study of Xchromosome inactivation in formalin-fixed paraffin-embedded tissue.Cancer Res 53(19): 4676-4679
18. Morandi L, Marucci G, Foschini MP, Cattani MG, Pession A, Riva C, EusebiV (2006) Genetic similarities and differences between lobular in situneoplasia (LN) and invasive lobular carcinoma of the breast. VirchowsArch 449(1): 14-23
19. Noguchi S, Yokouchi H, Aihara T, Motomura K, Inaji H, Imaoka S, KoyamaH (1995) Progression of fibroadenoma to phyllodes tumor demonstratedby clonal analysis. Cancer 76(10): 1779-1785
20. Radpour R, Fan AX, Kohler C, Holzgreve W, Zhong XY (2009) Currentunderstanding of mitochondrial DNA in breast cancer. Breast J 15(5):505-509
21. Salk JJ, Horwitz MS (2010) Passenger mutations as a marker of clonal celllineages in emerging neoplasia. Sem Cancer Biol 20(5): 294-303
22. Shadel GS (2008) Expression and maintenance of mitochondrialDNA: new insights into human disease pathology. Am J Pathol 172(6):1445-1456
23. Shen L, Fang H, Chen T, He J, Zhang M, Wei X, Xin Y, Jiang Y, Ding Z, Ji J,Lu J, Bai Y (2010) Evaluating mitochondrial DNA in cancer occurrenceand development. Ann N Y Acad Sci 1201: 26-33
24. Sokal RR, Michener CD (1958) A statistical method for evaluatingsystematic relationships. Univ Kansas Sci Bull 38: 1409-1438
25. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecularevolutionary genetics analysis (MEGA) software version 4.0. Mol BiolEvol 24(8): 1596-1599
26. Tan DJ, Bai RK, Wong LJ (2002) Comprehensive scanning of somaticmitochondrial DNA mutations in breast cancer. Cancer Res 62(4): 972-976
27. Tavassoli A, Devilee P (eds) (2003) Pathology & Genetics Tumours of theBreast and Female Genital Organs. International Agency for Research onCancer Press: Lyon
28. Teixeira MR, Heim S (2011) Cytogenetic analysis of tumor clonality. AdvCancer Res 112: 127-149
29. Teixeira MR, Pandis N, Heim S (2002) Cytogenetic clues to breastcarcinogenesis. Genes Chromosomes Cancer 33(1): 1-16
30. Teixeira MR, Ribeiro FR, Torres L, Pandis N, Andersen JA, Lothe RA, HeimS (2004) Assessment of clonal relationships in ipsilateral and bilateralmultiple breast carcinomas by comparative genomic hybridisation andhierarchical clustering analysis. Br J Cancer 91(4): 775-782
31. Teixeira MR, Tsarouha H, Kraggerud SM, Pandis N, Dimitriadis E,Andersen JA, Lothe RA, Heim S (2001) Evaluation of breast cancerpolyclonality by combined chromosome banding and comparativegenomic hybridization analysis. Neoplasia 3(3): 204-214
32. Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, Wei YH,Lee HC (2006) Mitochondrial DNA mutations and mitochondrialDNA depletion in breast cancer. Genes Chromosomes Cancer 45(7):629-638
33. Vicini FA, Antonucci JV, Goldstein N, Wallace M, Kestin L, Krauss D,Kunzmann J, Gilbert S, Schell S (2007) The use of molecular assays toestablish definitively the clonality of ipsilateral breast tumor recurrencesand patterns of in-breast failure in patients with early-stage breast cancertreated with breast-conserving therapy. Cancer 109(7): 1264-1272
34. Vogelstein B, Fearon ER, Hamilton SR, Feinberg AP (1985) Use ofrestriction fragment length polymorphisms to determine the clonalorigin of human tumors. Science 227(4687): 642-645
35. Wu Y, Basir Z, Kajdacsy-Balla A, Strawn E, Macias V, Montgomery K, GuoSW (2003) Resolution of clonal origins for endometriotic lesions usinglaser capture microdissection and the human androgen receptor(HUMARA) assay. Fertil Steril 79(Suppl 1): 710-717
36. Yu M (2011) Generation, function and diagnostic value of mitochondrialDNA copy number alterations in human cancers. Life Sci 89(3-4): 65-71
37. Yu M, Zhou Y, Shi Y, Ning L, Yang Y, Wei X, Zhang N, Hao X, Niu R (2007)Reduced mitochondrial DNA copy number is correlated with tumorprogression and prognosis in Chinese breast cancer patients. IUBMB life59(7): 450-457
38. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, Sauter ER (2005)Mitochondrial DNA mutations in breast cancer tissue and in matchednipple aspirate fluid. Carcinogenesis 26(1): 145-152